NomosLogic

Molecular Medicine Infrastructure

Deterministic
Molecular Medicine Infrastructure

NomosLogic turns genomic and multi-omic complexity into governed, reproducible, clinically usable intelligence for health systems, research, individuals and families, payers, and pharma.

The same variant can appear differently across consumer DNA, clinical sequencing, and research systems. If that layer is unstable, every downstream interpretation is unstable.

<30s

Genome Resolution

1.26M+

Clinical Logic Objects

497K+

Hardy Bridge Mappings

22M+

Anchored Molecular Reference Assets

Why This Matters

Genomics does not have a data problem.
It has an infrastructure problem.

Sequencing is cheap. Interpretation is not. Clinical genomics still depends on fragmented reference data, inconsistent variant calls, and opaque reasoning layers that cannot be reproduced, audited, or defended under regulatory scrutiny.

Most systems treat cross-system variant mismatch as a formatting problem. It is not. It is a substrate problem. Without deterministic identity resolution, anchored evidence, and governed logic, every downstream output inherits the same fragility as the data underneath it.

NomosLogic was built for the layer beneath interpretation: resolve variant identity across systems, execute deterministic clinical logic, and return auditable results that can actually be trusted.

What Makes NomosLogic Different

Built for governed clinical and scientific use

NomosLogic resolves variant identity, anchors evidence, and executes deterministic clinical logic across consumer, clinical, payer, and research environments.

Same input, same output

Every molecular result is produced by deterministic logic, not probabilistic inference, so it is reproducible across runs, sites, and time.

Findings trace to source

Every variant, every call, every interpretation resolves to a canonical reference: ClinVar, CPIC, FDA, GWAS, Hardy Bridge. Never to an opaque prior.

Logic is governed and versioned

Clinical rules are structured, immutable objects. When logic changes, prior outputs can be re-derived bit-for-bit; nothing drifts silently.

Outputs are clinically defensible

Every result carries provenance, evidence lineage, and policy state, the record required for regulatory review, payer audit, and clinician trust.

One layer, four execution domains

The same substrate serves consumer genomics, clinical genomics, payer infrastructure, and pharma research without forking the logic underneath.

This is the difference between generating more interpretation and building infrastructure that can actually be trusted.

Platform Proof

A molecular medicine substrate, not a point solution.

NomosLogic is powered by a production-scale infrastructure layer that includes:

22M+

Anchored Molecular Reference Assets

1.26M+

Structured Clinical Logic Objects

497K+

Hardy Bridge Variant Mappings

608+

FDA Drug-Gene Mandates

<30s

Deterministic Genome Resolution

<90s

Multi-Omic Fusion

These are not marketing surfaces. They are the substrate that makes deterministic molecular medicine possible.

Execution Domains

One infrastructure layer. Four execution domains.

The same deterministic substrate serves every stakeholder that needs molecular data to be trustworthy, reproducible, and usable in production.

Clinical Genomics

Delivers deterministic variant interpretation, pharmacogenomic guidance, and audit-ready reporting inside the clinical workflow, with SMART on FHIR integration, full provenance, and rapid genome resolution.

Consumer Genomics

Transforms consumer DNA files into governed, legible, clinically relevant molecular insight through the same resolution layer used across the platform.

Payer Infrastructure

Provides a structured evidence layer for utilization review, prior authorization, and population pharmacogenomics, grounded in FDA, CPIC, and ClinVar references rather than narrative rationale.

Pharma Research

Supports disease modeling, evolutionary resistance analysis, and trial stratification with reproducible, mechanism-anchored logic and validator-gated research outputs.

Engine Architecture

A deterministic engine stack built for real-world load

NomosLogic is composed of interoperable engines that resolve, map, govern, and execute molecular intelligence at scale. Each engine performs a defined role in a governed molecular medicine pipeline from variant resolution and evidence normalization to disease modeling and clinical execution.

Proprietary Translation Layer

The Hardy Bridge

A proprietary nomenclature translation layer with 497,335 enriched variant-to-phenotype mappings. Translates seamlessly between clinical nomenclature systems.

rsIDsHGVSStar AllelesChromosomal CoordinatesLOINCRxNormICD-10

Translation at Scale

Enriched Mappings497,335
Nomenclature Systems7
Pharmacogenes Covered23+
Est. Annual Savings (Hospital Networks)$10.1M

Architecture

Sovereign by Design

Pseudonymous Identity Bridge

Salted HMAC-based pseudonymous identity matching for cross-system linkage without exposing raw personal identifiers to the matcher.

Confidential Compute

Clinical logic executes inside AWS Nitro-backed private infrastructure with AES-256 encryption at rest, TLS 1.3 in transit, and k-anonymity enforced at the SQL layer. Patient data never crosses the public internet.

Cryptographic Audit Trail

Every clinical decision and disclosure is signed and logged. Disclosure events are immutable and audit-ready by design.

Deterministic molecular infrastructure for clinical and scientific use.

The future of molecular medicine will not be built on black-box clinical reasoning.

It will be built on deterministic infrastructure that is fast, governed, traceable, and reproducible under scrutiny. NomosLogic is building that layer.